v3.26.1
Supplemental Financial Information - Schedule of Supplemental Statement of Cash Flows (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Cash flows from operating activities      
Net income (loss) $ (141.9) $ 158.6  
Adjustments to reconcile net income to net cash flows from operating activities:      
Depreciation and amortization 50.5 46.9  
Equity-based compensation 119.8 103.5  
Non-cash performance allocations and incentive fees 283.1 15.0  
Non-cash principal investment (income) loss (39.6) 72.7  
Other non-cash amounts (2.1) 12.6  
Purchases of investments (148.2) (78.3)  
Proceeds from the sale of investments 160.8 144.8  
Payments of contingent consideration 0.0 (1.0)  
Changes in deferred taxes, net (45.4) (29.4)  
Change in due from affiliates and other receivables (1.7) 10.7  
Change in deposits and other 7.1 (10.8)  
Change in accounts payable, accrued expenses and other liabilities (66.1) (25.4)  
Change in accrued compensation and benefits (461.2) (327.7)  
Change in due to affiliates 18.0 6.5  
Change in lease right-of-use assets and lease liabilities (4.5) (2.8)  
Change in deferred revenue 229.8 280.2  
Net cash used in operating activities (1,242.4) (352.1)  
Cash flows from investing activities      
Purchases of fixed assets, net (28.1) (16.7)  
Net cash used in investing activities (28.1) (16.7)  
Cash flows from financing activities      
Payments on CLO borrowings (22.5) (14.6)  
Proceeds from CLO borrowings, net of financing costs 32.4 15.1  
Dividends to common stockholders (126.4) (126.4)  
Contributions from non-controlling interest holders 783.9 163.0  
Distributions to non-controlling interest holders (89.8) (164.2)  
Common shares repurchased and net share settlement of equity-based awards (204.8) (176.5)  
Change in due to/from affiliates financing activities 35.7 40.8  
Net cash provided by financing activities 988.3 296.6  
Effect of foreign exchange rate changes (8.7) 5.0  
Decrease in cash, cash equivalents and restricted cash (290.9) (67.2)  
Cash, cash equivalents and restricted cash, beginning of period 1,973.6 1,266.5  
Cash, cash equivalents and restricted cash, end of period 1,682.7 1,199.3  
Reconciliation of cash, cash equivalents and restricted cash, end of period:      
Cash and cash equivalents 1,673.2 1,190.3 $ 1,970.2
Restricted cash 9.5 9.0 3.4
Total cash, cash equivalents and restricted cash, end of period 1,682.7 1,199.3 1,973.6
Cash and cash equivalents held at Consolidated Funds 1,081.0 570.9 1,235.1
Consolidated Operating Entities      
Cash flows from operating activities      
Net income (loss) (139.4) 150.6  
Adjustments to reconcile net income to net cash flows from operating activities:      
Depreciation and amortization 50.5 46.9  
Equity-based compensation 119.8 103.5  
Non-cash performance allocations and incentive fees 282.0 14.5  
Non-cash principal investment (income) loss 17.4 69.6  
Other non-cash amounts (2.1) 12.6  
Purchases of investments (328.7) (290.9)  
Proceeds from the sale of investments 358.8 155.1  
Payments of contingent consideration 0.0 (1.0)  
Changes in deferred taxes, net (45.4) (29.4)  
Change in due from affiliates and other receivables (1.1) 12.7  
Change in deposits and other 7.1 (10.8)  
Change in accounts payable, accrued expenses and other liabilities (66.1) (25.4)  
Change in accrued compensation and benefits (461.2) (327.7)  
Change in due to affiliates 18.0 6.5  
Change in lease right-of-use assets and lease liabilities (4.5) (2.8)  
Change in deferred revenue 229.8 280.2  
Net cash used in operating activities 34.9 164.2  
Cash flows from investing activities      
Purchases of fixed assets, net (28.1) (16.7)  
Net cash used in investing activities (28.1) (16.7)  
Cash flows from financing activities      
Payments on CLO borrowings (22.5) (14.6)  
Proceeds from CLO borrowings, net of financing costs 32.4 15.1  
Dividends to common stockholders (126.4) (126.4)  
Contributions from non-controlling interest holders 51.7 57.7  
Distributions to non-controlling interest holders (59.6) (16.9)  
Common shares repurchased and net share settlement of equity-based awards (204.8) (176.5)  
Change in due to/from affiliates financing activities 36.9 42.3  
Net cash provided by financing activities (292.3) (219.3)  
Effect of foreign exchange rate changes (5.4) 4.6  
Decrease in cash, cash equivalents and restricted cash (290.9) (67.2)  
Cash, cash equivalents and restricted cash, beginning of period 1,973.6 1,266.5  
Cash, cash equivalents and restricted cash, end of period 1,682.7 1,199.3  
Reconciliation of cash, cash equivalents and restricted cash, end of period:      
Cash and cash equivalents 1,673.2 1,190.3  
Restricted cash 9.5 9.0  
Total cash, cash equivalents and restricted cash, end of period 1,682.7 1,199.3 $ 1,973.6
Cash and cash equivalents held at Consolidated Funds $ 1,081.0 $ 570.9